Retatrutide is not commercially available in the UK, meaning any product marketed as such is either counterfeit, mislabelled, or obtained through unregulated channels
Injectable GLP-1s: Nearly 100% bioavailability Consistent, predictable absorption Doses of 1-2.4mg weekly for semaglutide FDA-Approved Oral Tablets: 0.4-1% bioavailability Requires 7-25mg doses to achieve similar effects Must be taken with specific timing and fasting requirements Compounded ODT Formulations: Theoretical bioavailability advantage over swallowed tablets Sublingual/buccal delivery bypasses stomach acid and first-pass metabolism However, research on peptide delivery shows challenges: peptides may be degraded by salivary enzymes, have poor permeability due to large molecular size, and face continuous wash-away from saliva No clinical trials have established actual bioavailability or effectiveness for compounded GLP-1 ODTs These formulations are not FDA-approved and haven't undergone rigorous testing The theoretical advantage of ODT formulations is that by dissolving in the mouth rather than the stomach, they could achieve better absorption than swallowed tablets while maintaining the convenience of a daily, needle-free option
This experiment is my way of testing if Tirzepatide can serve as the metabolic training wheels I need to make this lifestyle sustainable
Lower fasting insulin
Does the light inside a refrigerator harm the reconstituted peptide
Haas break down GHK-Cu, the Glow stack, and the Klow stack what they are, how they work, how to use them properly, and why they belong in almost everyone's protocol
